Business·Industry

SamsungElectronics Expands HBM Market Share to 33%… SK Hynix Remains No. 1 with 50%

SamsungElectronics' HBM Market Share Jumps from 21% to 33% No. 1 SK hynix Falls from 58% to 50%… Maintains Top Spot "SamsungElectronics' Market Share Expected to Grow Further with HBM4 Launch"

SOYEON KIM
2026-09-03 16:32:24
[Edaily Reporter SOYEON KIM ] SamsungElectronics has significantly expanded its market share in the High-Bandwidth Memory (HBM) market, narrowing the gap with market leader SK hynix.

According to market research firm Counterpoint Research on the 3rd, SK hynix maintained its top position in the global HBM market in the second quarter of this year with a 50% revenue share. However, its market share fell by 8 percentage points from 58% in the previous quarter.

SamsungElectronics increased its market share by 12 percentage points, from 21% in the first quarter to 33% in the second quarter.

Counterpoint Research predicted that Samsung’s market share would gradually increase further as it ramps up HBM4 shipments.

Micron ranked third, capturing an 18% market share. This represents a slight decline from the previous quarter’s 21%.

Counterpoint Research projected, “Currently, the majority of HBM revenue comes from the fifth-generation product, HBM3E, and shipments of the sixth-generation HBM4 are expected to gain significant traction starting in the second half of this year.”

Economy

Corporation

IT·Science

Economy

SamsungElectronics Expands HBM Market Share to 33%… SK Hynix Remains No. 1 with 50%

SamsungElectronics has significantly expanded its market share in the High-Bandwidth Memory (HBM) market, narrowing the gap with market leader SK hynix.According to market research firm Counterpoint R…
2026-09-03 16:32:24

Corporation

“From Instant Delivery to Next-Day Delivery”… Speed Competition Heats Up in the Convenience Store Industry

Following the trend of same-day delivery, the domestic convenience store industry is now competing to offer next-day delivery services. This shift is driven by changes in consumer lifestyles, as the s…
2026-09-03 14:56:22

IT·Science

GenenCell, Backed by Kim Seung-won… Investment Value ‘Evaporates’ Amid Fabricated Data and Clinical Trial Suspension

The COVID-19 treatment developed by Genencell Co., Ltd.—for which Justice Minister nominee Kim Seung-won had requested expedited processing—has fallen through one year and seven months after receiving…
2026-09-03 15:56:01